Stocks
Bristol-Myers (BMY) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 7 440 | 5 035 | 20 191 | 19 232 | 19 417 | 5 032 | ||
| Changes by years, y/y, % | +23% | -32% | +301% | -5% | +1% | +26.2% | |||
Bristol-Myers. EBITDA US GAAP, bln rub
Bristol-Myers. EBITDA US GAAP, changes, %
Bristol-Myers. EBITDA US GAAP, sum by quarters, bln rub
Bristol-Myers (BMY) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | 4 850 | 4 453 | -8 536 | 4 368 | 4 747 | 5 032 | |
| Changes by years, y/y, % | -9% | -6% | -268% | -6% | -2% | |||
| Changes by quarters, q/q, % | +5% | -8% | -292% | -151% | +9% | |||
